Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adelaide A Hebert
Patient-Reported Outcomes From Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)
SKIN The Journal of Cutaneous Medicine
Related publications
Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial
British Journal of Haematology
Hematology
Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes From Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)
SKIN The Journal of Cutaneous Medicine
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials
RMD Open
Rheumatology
Allergy
Immunology
Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Feasibility of Double-Blind Clinical Trials With Oral Diacetylmorphine: A Randomized Controlled Phase II Study in an Inpatient Setting
European Addiction Research
Medicine
Psychiatry
Mental Health
Health
Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Safety and Efficacy of A-101 Hydrogen Peroxide Topical Solution in Adults With Seborrheic Keratosis: Results From the Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study
SKIN The Journal of Cutaneous Medicine
Accidental Exposures to Peanut and Other Food Allergens: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
